The downregulation of glutamine transporters (ASCT2 and LAT1) was able to reduce the uptake of glutamine in proliferating cells, thereby repressing NSCLC cell proliferation and inducing cell apoptosis by blocking the mTOR pathway [31]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.